1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Precision medicine in complex diseases - : Molecular subgrouping for improved prediction and treatment stratification
2023) In Journal of Internal Medicine(
- Contribution to journal › Scientific review
-
Mark
The small and large intestine contain related mesenchymal subsets that derive from embryonic Gli1 + precursors.
(
- Contribution to journal › Article
-
Mark
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
(
- Contribution to journal › Article
- 2022
-
Mark
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
(
- Contribution to journal › Article
-
Mark
Type I Interferons Promote Germinal Centers Through B Cell Intrinsic Signaling and Dendritic Cell Dependent Th1 and Tfh Cell Lineages
(
- Contribution to journal › Article
-
Mark
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
(
- Contribution to journal › Article
- 2021
-
Mark
Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes : A machine learning approach in the Diabetes Prevention Program
(
- Contribution to journal › Article
-
Mark
Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT : An IMI DIRECT Study
(
- Contribution to journal › Article
-
Mark
Processes Underlying Glycemic Deterioration in Type 2 Diabetes : An IMI DIRECT Study
(
- Contribution to journal › Article
-
Mark
Inferring causal pathways between metabolic processes and liver fat accumulation: an IMI DIRECT study
2021) In medRxiv(
- Working paper/Preprint › Preprint in preprint archive